|
Volumn 8, Issue 8, 1992, Pages 1451-1455
|
Development and Analysis of Recombinant BCG Vector Systems
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOSTRIDIUM TOXIN;
GLYCOPROTEIN GP 120;
GLYCOPROTEIN GP 41;
HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;
RECOMBINANT VACCINE;
VIRUS VECTOR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL MODEL;
ANTIBODY PRODUCTION;
ANTIGEN EXPRESSION;
BCG VACCINATION;
CELLULAR IMMUNITY;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMORAL IMMUNITY;
MOUSE;
NONHUMAN;
SIMIAN IMMUNODEFICIENCY VIRUS;
AIDS VACCINES;
ANIMAL;
ANTIBODIES, VIRAL;
ANTIGENS, VIRAL;
GENETIC VECTORS;
HIV ANTIBODIES;
HIV ANTIGENS;
HIV ENVELOPE PROTEIN GP120;
HIV ENVELOPE PROTEIN GP41;
HIV-1;
IMMUNITY, CELLULAR;
MICE;
MICE, INBRED BALB C;
MYCOBACTERIUM BOVIS;
RECOMBINANT FUSION PROTEINS;
SIV;
SUPPORT, U.S. GOV'T, P.H.S.;
VACCINES, SYNTHETIC;
VIRAL VACCINES;
|
EID: 0026675448
PISSN: 08892229
EISSN: 19318405
Source Type: Journal
DOI: 10.1089/aid.1992.8.1451 Document Type: Article |
Times cited : (9)
|
References (5)
|